1241: Ketamine | Skeptical Sunday

What It Covers

Nick Pell examines ketamine therapy for treatment-resistant depression, PTSD, and chronic pain, covering the science behind how it works, clinical versus recreational use, safety concerns, and the explosive growth of ketamine clinics from 60 in 2015 to over 2,000 today.

Key Questions Answered

• •Mechanism of action: Ketamine blocks NMDA receptors, triggering glutamate surges that increase neuroplasticity and brain-derived neurotrophic factor, essentially rewiring neural pathways rather than just flooding existing ones with serotonin like traditional SSRIs, producing effects within hours instead of weeks.
• •Clinical vetting requirements: Legitimate ketamine clinics conduct comprehensive intake processes including blood work, psychiatric evaluations, and screening for contraindications like schizophrenia, bipolar disorder, or borderline personality disorder, where ketamine can worsen psychosis, trigger hypomania, or increase self-harm tendencies rather than help.
• •Treatment structure and cost: Initial protocols typically involve daily sessions for one week at approximately 500 dollars per session, followed by gradually spaced maintenance doses with medical supervision including vital monitoring, as ketamine carries real overdose risk and requires professional handlers throughout treatment.
• •Red flags for unsafe providers: Avoid telehealth ketamine services, clinics marketing treatment as spa experiences or consciousness enhancement, and facilities without mental health professionals on staff. Legitimate treatment targets specific conditions like treatment-resistant depression, not vague wellness optimization or recreational altered states.